Latest Gild News and Updates : Gild updates, Gild News , Gild around the world

Nishadil

Washington | 20°C (overcast clouds)

The Enduring Allure of Dividend Growers: Champions, Contenders, and Challengers

Top story

The Enduring Allure of Dividend Growers: Champions, Contenders, and Challengers

In focus

Latest feed

The Surprising Calm: Why Healthcare ETFs Aren't Rattled by Pharma Price Cuts

CureVac's Crossroads: Why Wall Street Is Treading Carefully Towards 2026

The CAR-T Paradox: Why Arcellx Shares Tumbled Despite 100% Response Rate

Unlocking Value in Healthcare: A Prudent Path to S&P 500 Dividends

Latest headlines

Final Trades Unpacked: Strategic Plays in Auto, Energy, Payments, and Biotech

Final Trades Unpacked: Strategic Plays in Auto, Energy, Payments, and Biotech

Merck's Breakthrough: Islatravir-Doravirine Matches Leading HIV Treatment in Pivotal Trials

Merck's Breakthrough: Islatravir-Doravirine Matches Leading HIV Treatment in Pivotal Trials

A New Dawn in Lung Cancer Treatment: Gilead and Arcus's Investigational Therapy Shows Promising Survival Advantage

A New Dawn in Lung Cancer Treatment: Gilead and Arcus's Investigational Therapy Shows Promising Survival Advantage

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

Unearthing Hidden Gems: The Top 30 Most Undervalued S&P 500 Stocks for Astute Investors

Unearthing Hidden Gems: The Top 30 Most Undervalued S&P 500 Stocks for Astute Investors

Navigating the Storm: 20 Defensive Dividend Stocks to Weather a Government Shutdown

Navigating the Storm: 20 Defensive Dividend Stocks to Weather a Government Shutdown

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Gilead Taps Veeva Vault CRM for Global Commercial Transformation

Gilead Taps Veeva Vault CRM for Global Commercial Transformation

Gilead Sciences Pioneers Future of Manufacturing with New California Development Site

Gilead Sciences Pioneers Future of Manufacturing with New California Development Site

A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy

A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy

Walgreens Supercharges Specialty Pharmacy Network Amid Surging Demand for Life-Changing Therapies

Walgreens Supercharges Specialty Pharmacy Network Amid Surging Demand for Life-Changing Therapies

First RSV shots, groundbreaking gene therapy among 2024 drugs to watch

First RSV shots, groundbreaking gene therapy among 2024 drugs to watch

Load more